Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:omipalisib
go back to main search page
Accession:CHEBI:95093 term browser browse the term
Definition:A member of the class of quinolines that is quinoline which is substituted by pyridazin-4-yl and 5-[(2,4-difluorobenzene-1-sulfonyl)amino]-6-methoxypyridin-3-yl groups at positions 4 and 6, respectively. It is a highly potent inhibitor of PI3K and mTOR developed by GlaxoSmithKline and was previously in human phase 1 clinical trials for the treatment of idiopathic pulmonary fibrosis and solid tumors.
Synonyms:exact_synonym: 2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzenesulfonamide
 related_synonym: 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide;   2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide;   2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzene-1-sulfonamide;   Formula=C25H17F2N5O3S;   GSK 2126458;   GSK-212;   GSK-458;   GSK212;   GSK2126458;   GSK458;   InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3;   InChIKey=CGBJSGAELGCMKE-UHFFFAOYSA-N;   SMILES=COC1=C(NS(=O)(=O)C2=CC=C(F)C=C2F)C=C(C=N1)C1=CC2=C(C=CN=C2C=C1)C1=CN=NC=C1;   omipalisibum
 xref: CAS:1086062-66-9;   Chemspider:25027388;   DrugBank:DB12703;   KEGG:D10718
 xref_mesh: MESH:C561454
 xref: PDBeChem:ZIG;   PMID:21464613;   PMID:22297110;   PMID:22389471;   PMID:24392766;   PMID:24900173;   PMID:25170609;   PMID:25298748;   PMID:25504751;   PMID:25659532;   PMID:26603258;   PMID:26604245;   PMID:26819001;   PMID:27450049;   PMID:28938574;   PMID:29487419;   PMID:29976629;   PMID:30133440;   PMID:30765508;   PMID:31494146;   PMID:32381012;   PMID:32382996;   PMID:32804918;   PMID:33360802;   PMID:33521022;   PMID:34234012;   PMID:34284231;   PMID:34330845;   PMID:34461940



show annotations for term's descendants           Sort by:
 
omipalisib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions
decreases phosphorylation
ISO [omipalisib co-treated with trametinib] results in decreased phosphorylation of AKT1 protein
omipalisib results in decreased phosphorylation of AKT1 protein
CTD PMID:22733540 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions ISO [trametinib co-treated with omipalisib] results in increased expression of BCL2L11 protein CTD PMID:22733540 NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
JBrowse link
G Casp3 caspase 3 multiple interactions ISO [GNAQ gene mutant form results in increased susceptibility to [trametinib co-treated with omipalisib]] which results in increased cleavage of CASP3 protein CTD PMID:22733540 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp7 caspase 7 multiple interactions ISO [GNAQ gene mutant form results in increased susceptibility to [trametinib co-treated with omipalisib]] which results in increased cleavage of CASP7 protein CTD PMID:22733540 NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
JBrowse link
G Ddr1 discoidin domain receptor tyrosine kinase 1 multiple interactions ISO omipalisib enhances the reaction [DDR1-IN-1 inhibits the reaction [collagen increases DDR1 autophosphorylation in human cell lines]] RGD PMID:23899692 RGD:152995467 NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 decreases phosphorylation ISO omipalisib results in decreased phosphorylation of EIF4EBP1 protein CTD PMID:22733540 NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
JBrowse link
G Gnaq G protein subunit alpha q multiple interactions ISO [GNAQ gene mutant form results in increased susceptibility to [trametinib co-treated with omipalisib]] which results in increased cleavage of CASP3 protein; [GNAQ gene mutant form results in increased susceptibility to [trametinib co-treated with omipalisib]] which results in increased cleavage of CASP7 protein; GNAQ gene mutant form results in increased susceptibility to [trametinib co-treated with omipalisib] CTD PMID:22733540 NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [omipalisib co-treated with trametinib] results in increased phosphorylation of JUN protein; JUN results in decreased susceptibility to [omipalisib co-treated with trametinib] CTD PMID:22733540 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
ISO [omipalisib co-treated with trametinib] results in decreased phosphorylation of MAPK1 protein
omipalisib results in increased phosphorylation of MAPK1 protein
CTD PMID:22733540 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
ISO [omipalisib co-treated with trametinib] results in decreased phosphorylation of MAPK3 protein
omipalisib results in increased phosphorylation of MAPK3 protein
CTD PMID:22733540 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases phosphorylation
increases cleavage
ISO omipalisib results in decreased phosphorylation of PARP1 protein
omipalisib results in increased cleavage of PARP1 protein
CTD PMID:21464613 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
JBrowse link
G Rps6 ribosomal protein S6 decreases phosphorylation ISO omipalisib results in decreased phosphorylation of RPS6 protein CTD PMID:21464613 NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602
Ensembl chr 5:101,371,136...101,374,602
JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 decreases phosphorylation ISO omipalisib results in decreased phosphorylation of RPS6KB1 protein CTD PMID:21464613 PMID:22733540 NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20057
    role 20023
      biological role 20010
        biochemical role 19662
          autophagy inducer 1353
            omipalisib 13
Path 2
Term Annotations click to browse term
  CHEBI ontology 20057
    subatomic particle 20056
      composite particle 20068
        hadron 20056
          baryon 20056
            nucleon 20056
              atomic nucleus 20056
                atom 20056
                  main group element atom 19971
                    p-block element atom 19971
                      chalcogen 19711
                        oxygen atom 19681
                          oxygen molecular entity 19681
                            hydroxides 19434
                              oxoacid 18741
                                chalcogen oxoacid 11735
                                  sulfur oxoacid 11369
                                    sulfonic acid 7657
                                      sulfonic acid derivative 7657
                                        sulfonamide 3212
                                          omipalisib 13
paths to the root